LONDON, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a neuroscience company focused on psychedelic-assisted therapies for mental ...
A community-based study suggests a correlation between university education and the likelihood of disease-modifying therapy (DMT) uptake in multiple sclerosis (MS). Having a university education was ...
A new study from Imperial College London has found significant overlap between the experiences reported by subjects who have had near-death experiences, and volunteers administered with a powerful ...
Benjamin holds a Master's degree in anthropology from University College London and has previously worked in the fields of psychedelic neuroscience and mental health. Benjamin holds a Master's degree ...
Advanced brain imaging in a study from a team of U.K.-based scientists shows how dimethyltryptamine (DMT) alters perception of reality by changing communication and connectivity. According to a March ...
LONDON--(BUSINESS WIRE)--Small Pharma Inc., a neuroscience company focused on psychedelic-assisted therapies for mental health, is pleased to share the analysis of Phase I data from the combined Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback